Article Details

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion - CNBC

Retrieved on: 2023-12-07 17:24:14

Tags for this article:

Click the tags to see associated articles and topics

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion - CNBC. View article details on hiswai:

Excerpt

05:11. AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion ; 03:57. Microsoft is leading the way in AI, says Wedbush's Dan ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo